O'CONNOR DANIEL J. (President and CEO) received a stock award from AMBRX BIOPHARMA CAYMAN, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/28/2023ACC: 0001209191-23-026093
DirectorOfficer· President and CEO
Since Jan 2023
+2.75M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
2.75M acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+2.75M
Price / share
—
Trade value
—
% of position
New position
4/26/2023
0.00→2.75M
Total
Net shares
+2.75M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/26/2023 | A · Award | +2.75M | — | — | New position | 0.00 | 2.75M |
| Total | +2.75M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported